BOPA 2017 | Promising results from the uMotif app for CRC

Nina Paton

Digital technologies can aid both patients and clinicians in managing a disease. Here, Nina Paton from The Christie NHS Foundation Trust, Manchester, UK discusses the exciting results of a pilot study of a colorectal cancer symptom-tracking app, uMotif, that was run at the center as part of the Cancer Vanguard Medicines Optimisation programme. Following this success, Ms Paton describes plans for further investigation of the app. This video was recorded at the British Oncology Pharmacy Association (BOPA) 20th Annual Symposium 2017 in Glasgow, UK.

Share this video